As part of its Project DAWN initiative, MetroHealth in Cleveland has outfitted an RV it can use to distribute naloxone, serve as a syringe exchange and provide other resources to at-risk individuals in Northeast Ohio.
Spark Biomedical, a Texas-based medical device company, announced that the FDA has granted 510(k) clearance for its Sparrow Therapy System, a wearable neurostimulation device for the treatment of opioid withdrawal.
Nicotine and marijuana vaping among teens did not increase from 2019 into early 2020, but use among this population remains high, according to data from the Monitoring the Future survey released this week.
The initiative at Boston Medical Center's Grayken Center is a six-month program that provides clinical experiential training and didactic learning opportunities to educate registered nurses on treating patients with substance use disorders.
Opioid overdose deaths involving multiple substances among youth were found to be more common than overdose deaths involving only opioids, per the results of a study recently published by the Grayken Center at Boston Medical Center.
Patients who leave against medical advice put themselves at risk. Additional concerns for the treatment center could include liability for patient self-harm, overdose, suicide or injury from a lack of basic safety. Such risk can be minimized,…
Even though it is difficult to find out the facts about the separation of immigrant children from their parents along our southwest border, there are certain clinical and ethical principles that we must reaffirm to our colleagues, the public and…